213 related articles for article (PubMed ID: 19498323)
21. Sleep-disordered breathing in school-aged children with Prader-Willi syndrome.
Schaefer J; Davey MJ; Nixon GM
J Clin Sleep Med; 2022 Apr; 18(4):1055-1061. PubMed ID: 34870583
[TBL] [Abstract][Full Text] [Related]
22. Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study.
Miller JL; Shuster J; Theriaque D; Driscoll DJ; Wagner M
J Clin Sleep Med; 2009 Oct; 5(5):448-53. PubMed ID: 19961030
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Hagenäs L; Ritzén EM
Horm Res; 1999; 51(4):157-61. PubMed ID: 10474015
[TBL] [Abstract][Full Text] [Related]
24. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
25. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition.
Williams K; Scheimann A; Sutton V; Hayslett E; Glaze DG
J Clin Sleep Med; 2008 Apr; 4(2):111-8. PubMed ID: 18468308
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
[TBL] [Abstract][Full Text] [Related]
27. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?
Vandeleur M; Davey MJ; Nixon GM
J Paediatr Child Health; 2013 Mar; 49(3):238-41. PubMed ID: 23438058
[TBL] [Abstract][Full Text] [Related]
28. Preserved Sleep for the Same Level of Respiratory Disturbance in Children with Prader-Willi Syndrome.
Tan Q; He XTT; Kang S; Haqq AM; MacLean JE
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142494
[TBL] [Abstract][Full Text] [Related]
29. Somatropin therapy in adults with Prader-Willi syndrome.
Höybye C; Thorén M
Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
[TBL] [Abstract][Full Text] [Related]
30. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
31. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
32. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
Gao Y; Yang LL; Dai YL; Shen Z; Zhou Q; Zou CC
Orphanet J Rare Dis; 2023 Feb; 18(1):25. PubMed ID: 36750945
[TBL] [Abstract][Full Text] [Related]
33. Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment.
Palmieri VV; Lonero A; Bocchini S; Cassano G; Convertino A; Corica D; Crinò A; Fattorusso V; Ferraris S; Fintini D; Franzese A; Grugni G; Iughetti L; Lia R; Macchi F; Madeo SF; Matarazzo P; Nosetti L; Osimani S; Pajno R; Patti G; Pellegrin MC; Perri A; Ragusa L; Rutigliano I; Sacco M; Salvatoni A; Scarano E; Stagi S; Tornese G; Trifirò G; Wasniewska M; Fischetto R; Giordano P; Licenziati MR; Delvecchio M;
Growth Horm IGF Res; 2019; 48-49():9-15. PubMed ID: 31487604
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
Höybye C; Hilding A; Jacobsson H; Thorén M
Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
[TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis.
Sanchez-Ortiga R; Klibanski A; Tritos NA
Clin Endocrinol (Oxf); 2012 Jul; 77(1):86-93. PubMed ID: 22117629
[TBL] [Abstract][Full Text] [Related]
36. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
Lundberg E; Kriström B; Zouater H; Deleskog A; Höybye C
BMC Endocr Disord; 2020 Apr; 20(1):55. PubMed ID: 32349731
[TBL] [Abstract][Full Text] [Related]
37. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.
Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G
J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173
[TBL] [Abstract][Full Text] [Related]
38. Sleep-disordered breathing in Australian children with Prader-Willi syndrome following initiation of growth hormone therapy.
Caudri D; Nixon GM; Nielsen A; Mai L; Hafekost CR; Kapur N; Seton C; Tai A; Blecher G; Ambler G; Bergman PB; Vora KA; Crock P; Verge CF; Tham E; Musthaffa Y; Lafferty AR; Jacoby P; Wilson AC; Downs J; Choong CS
J Paediatr Child Health; 2022 Feb; 58(2):248-255. PubMed ID: 34397126
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
40. Psychomotor development in infants with Prader-Willi syndrome and associations with sleep-related breathing disorders.
Festen DA; Wevers M; de Weerd AW; van den Bossche RA; Duivenvoorden HJ; Otten BJ; Wit JM; Hokken-Koelega AC
Pediatr Res; 2007 Aug; 62(2):221-4. PubMed ID: 17597659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
